Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

Thursday’s trading has closed, but SUPN is being traded in the after-hours session. After-Hours quote »
16.75
Delayed Data
As of 3:59pm ET
 -0.21 / -1.24%
Today’s Change
7.31
Today|||52-Week Range
18.55
+101.81%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Supernus Pharmaceuticals Inc have a median target of 22.50, with a high estimate of 35.00 and a low estimate of 18.00. The median estimate represents a +34.33% increase from the last price of 16.75.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Supernus Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.02
Sales
$34.1M
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -20.00%
 
 
 
 
 
 
Growthannually -51.56%
 
 
 
 
 
 

Sales

Growthquarterly 21.09%
 
 
 
 
 
 
Growthannually 13.49%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account